217 related articles for article (PubMed ID: 16385230)
1. AICAR, an AMPK activator, has protective effects on alcohol-induced fatty liver in rats.
Tomita K; Tamiya G; Ando S; Kitamura N; Koizumi H; Kato S; Horie Y; Kaneko T; Azuma T; Nagata H; Ishii H; Hibi T
Alcohol Clin Exp Res; 2005 Dec; 29(12 Suppl):240S-5S. PubMed ID: 16385230
[TBL] [Abstract][Full Text] [Related]
2. Addition of adenosine monophosphate-activated protein kinase activators to University of Wisconsin solution: a way of protecting rat steatotic livers.
Ben Mosbah I; Massip-Salcedo M; Fernández-Monteiro I; Xaus C; Bartrons R; Boillot O; Roselló-Catafau J; Peralta C
Liver Transpl; 2007 Mar; 13(3):410-25. PubMed ID: 17326058
[TBL] [Abstract][Full Text] [Related]
3. The role of AMP-activated protein kinase in the action of ethanol in the liver.
You M; Matsumoto M; Pacold CM; Cho WK; Crabb DW
Gastroenterology; 2004 Dec; 127(6):1798-808. PubMed ID: 15578517
[TBL] [Abstract][Full Text] [Related]
4. Ethanol consumption impairs regulation of fatty acid metabolism by decreasing the activity of AMP-activated protein kinase in rat liver.
García-Villafranca J; Guillén A; Castro J
Biochimie; 2008 Mar; 90(3):460-6. PubMed ID: 17997005
[TBL] [Abstract][Full Text] [Related]
5. AICAR, an AMPK activator, protects against cisplatin-induced acute kidney injury through the JAK/STAT/SOCS pathway.
Tsogbadrakh B; Ryu H; Ju KD; Lee J; Yun S; Yu KS; Kim HJ; Ahn C; Oh KH
Biochem Biophys Res Commun; 2019 Feb; 509(3):680-686. PubMed ID: 30616891
[TBL] [Abstract][Full Text] [Related]
6. The Adenosine Monophosphate (AMP) Analog, 5-Aminoimidazole-4-Carboxamide Ribonucleotide (AICAR) Inhibits Hepatosteatosis and Liver Tumorigenesis in a High-Fat Diet Murine Model Treated with Diethylnitrosamine (DEN).
Gao J; Xiong R; Xiong D; Zhao W; Zhang S; Yin T; Zhang X; Jiang G; Yin Z
Med Sci Monit; 2018 Nov; 24():8533-8543. PubMed ID: 30474622
[TBL] [Abstract][Full Text] [Related]
7. Repression of protein synthesis and mTOR signaling in rat liver mediated by the AMPK activator aminoimidazole carboxamide ribonucleoside.
Reiter AK; Bolster DR; Crozier SJ; Kimball SR; Jefferson LS
Am J Physiol Endocrinol Metab; 2005 May; 288(5):E980-8. PubMed ID: 15613684
[TBL] [Abstract][Full Text] [Related]
8. Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR.
Sakamoto K; Göransson O; Hardie DG; Alessi DR
Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E310-7. PubMed ID: 15068958
[TBL] [Abstract][Full Text] [Related]
9. AMP-activated protein kinase activation by AICAR increases both muscle fatty acid and glucose uptake in white muscle of insulin-resistant rats in vivo.
Iglesias MA; Furler SM; Cooney GJ; Kraegen EW; Ye JM
Diabetes; 2004 Jul; 53(7):1649-54. PubMed ID: 15220186
[TBL] [Abstract][Full Text] [Related]
10. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?
Corton JM; Gillespie JG; Hawley SA; Hardie DG
Eur J Biochem; 1995 Apr; 229(2):558-65. PubMed ID: 7744080
[TBL] [Abstract][Full Text] [Related]
11. Long-term AICAR administration and exercise prevents diabetes in ZDF rats.
Pold R; Jensen LS; Jessen N; Buhl ES; Schmitz O; Flyvbjerg A; Fujii N; Goodyear LJ; Gotfredsen CF; Brand CL; Lund S
Diabetes; 2005 Apr; 54(4):928-34. PubMed ID: 15793229
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of AMPK suppression of LXR-dependent Srebp-1c transcription.
Yap F; Craddock L; Yang J
Int J Biol Sci; 2011; 7(5):645-50. PubMed ID: 21647332
[TBL] [Abstract][Full Text] [Related]
13. 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo.
Hasenour CM; Ridley DE; Hughey CC; James FD; Donahue EP; Shearer J; Viollet B; Foretz M; Wasserman DH
J Biol Chem; 2014 Feb; 289(9):5950-9. PubMed ID: 24403081
[TBL] [Abstract][Full Text] [Related]
14. Identification of 5' AMP-activated kinase as a target of reactive aldehydes during chronic ingestion of high concentrations of ethanol.
Shearn CT; Backos DS; Orlicky DJ; Smathers-McCullough RL; Petersen DR
J Biol Chem; 2014 May; 289(22):15449-62. PubMed ID: 24722988
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological activators of AMP-activated protein kinase have different effects on Na+ transport processes across human lung epithelial cells.
Woollhead AM; Sivagnanasundaram J; Kalsi KK; Pucovsky V; Pellatt LJ; Scott JW; Mustard KJ; Hardie DG; Baines DL
Br J Pharmacol; 2007 Aug; 151(8):1204-15. PubMed ID: 17603555
[TBL] [Abstract][Full Text] [Related]
16. AICAR inhibits the Na+/H+ exchanger in rat hearts--possible contribution to cardioprotection.
Moopanar TR; Xiao XH; Jiang L; Chen ZP; Kemp BE; Allen DG
Pflugers Arch; 2006 Nov; 453(2):147-56. PubMed ID: 16983558
[TBL] [Abstract][Full Text] [Related]
17. Evidence for AMPK-dependent regulation of exocytosis of lipoproteins in a model liver cell line.
Puljak L; Parameswara V; Dolovcak S; Waldrop SL; Emmett D; Esser V; Fitz JG; Kilic G
Exp Cell Res; 2008 Jun; 314(10):2100-9. PubMed ID: 18405894
[TBL] [Abstract][Full Text] [Related]
18. C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase.
Kim EK; Miller I; Aja S; Landree LE; Pinn M; McFadden J; Kuhajda FP; Moran TH; Ronnett GV
J Biol Chem; 2004 May; 279(19):19970-6. PubMed ID: 15028725
[TBL] [Abstract][Full Text] [Related]
19. Adenosine monophosphate-activated protein kinase and nitric oxide in rat steatotic liver transplantation.
Carrasco-Chaumel E; Roselló-Catafau J; Bartrons R; Franco-Gou R; Xaus C; Casillas A; Gelpí E; Rodés J; Peralta C
J Hepatol; 2005 Dec; 43(6):997-1006. PubMed ID: 16085333
[TBL] [Abstract][Full Text] [Related]
20. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.
Jiang SJ; Dong H; Li JB; Xu LJ; Zou X; Wang KF; Lu FE; Yi P
World J Gastroenterol; 2015 Jul; 21(25):7777-85. PubMed ID: 26167077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
